Vectura Group

Vectura's product development, formulation and drug delivery expertise is centred around developing inhaled products to address unmet needs in airways diseases. Vectura has established development collaborations, joint ventures and license agreements with several global pharmaceutical and biotechnology companies. Vectura is based in the UK, with headquarters in Chippenham, Wiltshire and operates in Cambridge (UK), Germany and a US operations office near Boston MA.
Chippenham, GB
243 (est)

Vectura Group Locations

Chippenham, GB

Vectura Group Metrics

Vectura Group Summary

Market capitalization

£803 M

Closing share price


Vectura Group Financials

FY, 2014FY, 2015FY, 2016


£36.5 M£58 M£72 M

Revenue growth, %


Cost of sales

£1 M£2.4 M£3.3 M

Gross profit

£35.5 M£55.6 M£68.7 M

Gross profit Margin, %


Operating expense total

£41.7 M£62.6 M£73.8 M

Vectura Group Market Value History

Vectura Group News

Vectura Group Company Life

You may also be interested in